This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The panel was moderated by Denise Snyder, MS, RD, LDN, Associate Dean for ClinicalResearch, Duke University School of Medicine. “We this morning (May 4).
What could we accomplish in the next decades if we could clear away the barriers and break down the silos that still plague clinicalresearch? As clinicalresearch professionals, we know what we must do to improve efficiency and get drugs to patients faster. In a recent survey of random U.S.
While considered a relatively new class of cancer drugs, isotopes employed as radiation therapy is not a new concept. There are many radiopharmaceutical agents that are approved by the US Food and Drug Administration (FDA). How does Radiopharmaceutical Therapy Work? Figure courtesy of Boschi et al., 2019, 9(12), 2526.
She received the Christine Pierre Clinical Trials Lifetime Achievement Award in 2023 and is the 2025 Chair of the Board of Trustees for ACRP. She is a member of the Clinical Trial Transformation Initiative, in collaboration with Duke University andthe U.S.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content